Comparison data between NASH-HCC patients and our NASH-HCC model
We have acquired the gene expression data (RNA-seq data) using our STAMTM model. Additionally, we have compared the gene expression data between the STAMTM model and NASH-HCC patients.
As a result, we found that many of the gene expression changes were common in both the STAMTM model mice and NASH-HCC patients as well as non-NASH related HCC patients. If you interested in learning more about this gene expression comparison data, please contact us! We are always happy to answer our clients’ questions!
The STAMTM model, which is the world’s first mouse model to show the progression of NASH to liver cancer, was developed by SMC Laboratories. The STAMTM model develops a pathology similar to human NASH (fatty liver → NASH → liver fibrosis → HCC). Why not try using the STAMTM model to examine the gene expression of your target and use it in your research?